<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mrj</journal-id><journal-title-group><journal-title xml:lang="ru">Современная ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Modern Rheumatology Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1996-7012</issn><issn pub-type="epub">2310-158X</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1996-7012-2022-5-38-45</article-id><article-id custom-type="elpub" pub-id-type="custom">mrj-1343</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>Особенности клинического течения, лабораторных и инструментальных маркеров сосудистого воспаления в киргизской когорте больных артериитом Такаясу</article-title><trans-title-group xml:lang="en"><trans-title>Clinical course, laboratory and instrumental markers of vascular inflammation in the Kyrgyz cohort of patients with Takayasu's arteritis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5433-3300</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Койлубаева</surname><given-names>Г. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Koilubaeva</surname><given-names>G. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гулазык Маликовна Койлубаева</p><p>Кыргызская Республика, 720040, Бишкек, ул. Тоголока Молдо, 3</p></bio><bio xml:lang="en"><p>Gulazyk M. Koilubaeva</p><p>3, Togoloka Moldo Street, Bishkek 720040, Kyrgyz Republic</p></bio><email xlink:type="simple">makmal@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1880-5678</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Болотбекова</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Bolotbekova</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кыргызская Республика, 720040, Бишкек, ул. Тоголока Молдо, 3</p></bio><bio xml:lang="en"><p>3, Togoloka Moldo Street, Bishkek 720040, Kyrgyz Republic</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4846-5531</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Егорова</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Egorova</surname><given-names>O. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А </p></bio><bio xml:lang="en"><p>34A, Kashirskoe Shosse, Moscow 115522</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1189-3698</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Туратбекова</surname><given-names>А. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Turatbekova</surname><given-names>A. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кыргызская Республика, 720040, Бишкек, ул. Тоголока Молдо, 3</p></bio><bio xml:lang="en"><p>3, Togoloka Moldo Street, Bishkek 720040, Kyrgyz Republic</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тарасова</surname><given-names>Г. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Tarasova</surname><given-names>G. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А </p></bio><bio xml:lang="en"><p>34A, Kashirskoe Shosse, Moscow 115522</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3871-2324</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Суйунбай кызы</surname><given-names>Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Suyunbai kyzy</surname><given-names>G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кыргызская Республика, 720040, Бишкек, ул. Тоголока Молдо, 3</p></bio><bio xml:lang="en"><p>3, Togoloka Moldo Street, Bishkek 720040, Kyrgyz Republic</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5842-5066</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чукубаев</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chukubaev</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кыргызская Республика, 720040, Бишкек, ул. Тоголока Молдо, 3</p></bio><bio xml:lang="en"><p>3, Togoloka Moldo Street, Bishkek 720040, Kyrgyz Republic</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7274-264X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Турдукулов</surname><given-names>З. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Turdukulov</surname><given-names>Z. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кыргызская Республика, 720040, Бишкек, ул. Тоголока Молдо, 3</p></bio><bio xml:lang="en"><p>3, Togoloka Moldo Street, Bishkek 720040, Kyrgyz Republic</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0040-4684</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Усупбаева</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Usupbaeva</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кыргызская Республика, 720040, Бишкек, ул. Тоголока Молдо, 3</p></bio><bio xml:lang="en"><p>3, Togoloka Moldo Street, Bishkek 720040, Kyrgyz Republic</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный центр кардиологии и терапии им. акад. Мирсаида Миррахимова при Министерстве здравоохранения Кыргызской республики</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Center for Cardiology and Therapy named after acad. Mirsaida Mirrakhimova, Ministry of Health of the Kyrgyz Republic</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>18</day><month>10</month><year>2022</year></pub-date><volume>16</volume><issue>5</issue><fpage>38</fpage><lpage>45</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Койлубаева Г.М., Болотбекова А.М., Егорова О.Н., Туратбекова А.Т., Тарасова Г.М., Суйунбай кызы Г., Чукубаев М.А., Турдукулов З.Э., Усупбаева Д.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Койлубаева Г.М., Болотбекова А.М., Егорова О.Н., Туратбекова А.Т., Тарасова Г.М., Суйунбай кызы Г., Чукубаев М.А., Турдукулов З.Э., Усупбаева Д.А.</copyright-holder><copyright-holder xml:lang="en">Koilubaeva G.M., Bolotbekova A.M., Egorova O.N., Turatbekova A.T., Tarasova G.M., Suyunbai kyzy G., Chukubaev M.A., Turdukulov Z.E., Usupbaeva D.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://mrj.ima-press.net/mrj/article/view/1343">https://mrj.ima-press.net/mrj/article/view/1343</self-uri><abstract><p>Трудности своевременной верификации артериита Такаясу (АТ) обусловлены отсутствием высокочувствительных и специфических методов лабораторной и инструментальной диагностики.</p><p>Цель исследования – анализ клинического течения, лабораторных и инструментальных маркеров сосудистого воспаления в киргизской когорте больных АТ.</p><sec><title>Пациенты и методы</title><p>Пациенты и методы. В исследование включено 75 больных с достоверным диагнозом АТ, находившихся на стационарном лечении и наблюдавшихся амбулаторно в клинике Национального центра кардиологии и терапии им. акад. Мирсаида Миррахимова с января 2011 по апрель 2022 г. Обследование больных с использованием клинических, лабораторных и инструментальных методов проводилось 1 раз в 2 года. Срок наблюдения составил у 45 (60%) пациентов 1–5 лет и у остальных 30 (40%) 6–15 лет. Всем пациентам проведены клиническое и стандартное лабораторное обследование с определением уровня СРБ и интерлейкина 6, а также ультразвуковая допплерография периферических артерий в режиме цветового допплеровского картирования и мультиспиральная компьютерная томография-панаортография.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. В основном выявлялось поражение общих сонных (85,33%) и подключичных (84%) артерий. Вовлечение брюшной аорты отмечалось у 60% больных и в 100% случаев сопровождалось стенозом почечных артерий. Клиническая картина заболевания была представлена преимущественно кардиальной патологией в виде артериальной гипертензии (84%) и аортальной регургитации (68%) с развитием декомпенсированной хронической сердечной недостаточности у 15% больных. При динамическом наблюдении значимого улучшения течения болезни, клинических симптомов, уменьшения выраженности сосудистых изменений не выявлено, за исключением снижения клинической активности АТ (p&lt;0,05) у трети больных (37,4%). Заключение. Тяжесть клинических проявлений и течения АТ в киргизской когорте была обусловлена сердечно-сосудистой патологией. Как показало динамическое наблюдение, отсутствие значимого улучшения в течении болезни во многом было связано с большой длительностью хронического воспаления, поздней диагностикой, развитием необратимых стенотических, окклюзионных и аневризматических изменений, а также с тем, что больные не получали адекватную патогенетическую терапию в дебюте заболевания. Ключевые слова: артериит Такаясу; активность; аневризма; мониторинг; стеноз; окклюзия; ультразвуковая допплерография; томография. Контакты: Гулазык Маликовна Койлубаева; makmal@rambler.ru Для ссылки: Койлубаева ГМ, Болотбекова АМ, Егорова ОН и др. Особенности клинического течения, лабораторных и инструментальных маркеров сосудистого воспаления в киргизской когорте больных артериитом Такаясу. Современная ревматология. 2022;16(5): 38–45. DOI: 10.14412/1996-7012-2022-5-38-45 Clinical course, laboratory and instrumental markers of vascular inflammation in the Kyrgyz cohort of patients with Takayasu's arteritis Koilubaeva G.M.1 , Bolotbekova A.M.1 , Egorova O.N.2 , Turatbekova A.T.1 , Tarasova G.M.2 , Suyunbai kyzy G.1 , Chukubaev M.A.1 , Turdukulov Z.E.1 , Usupbaeva D.A.1 1 National Center for Cardiology and Therapy named after acad. Mirsaida Mirrakhimova, Ministry of Health of the Kyrgyz Republic, Bishkek; 2 V.A. Nasonova Research Institute of Rheumatology, Moscow 1 3, Togoloka Moldo Street, Bishkek 720040, Kyrgyz Republic; 2 34A, Kashirskoe Shosse, Moscow 115522, Russia Lack of highly sensitive and specific methods of laboratory and instrumental diagnostics leads to difficulties in timely verification of Takayasu's arteritis (AT)&gt;&lt;0,05) у трети больных (37,4%).</p></sec><sec><title>Заключение</title><p>Заключение. Тяжесть клинических проявлений и течения АТ в киргизской когорте была обусловлена сердечно-сосудистой патологией. Как показало динамическое наблюдение, отсутствие значимого улучшения в течении болезни во многом было связано с большой длительностью хронического воспаления, поздней диагностикой, развитием необратимых стенотических, окклюзионных и аневризматических изменений, а также с тем, что больные не получали адекватную патогенетическую терапию в дебюте заболевания.</p></sec></abstract><trans-abstract xml:lang="en"><p>Lack of highly sensitive and specific methods of laboratory and instrumental diagnostics leads to difficulties in timely verification of Takayasu's arteritis (AT).</p><sec><title>Objective</title><p>Objective: to analyze the clinical course, laboratory and instrumental markers of vascular inflammation in the Kyrgyz cohort of patients with AT.</p></sec><sec><title>Patients and methods</title><p>Patients and methods. The study included 75 patients with a reliable diagnosis of AT, who were hospitalized and observed on an outpatient basis at the clinic of the National Center for Cardiology and Therapy named after acad. Mirsaida Mirrakhimova from January 2011 to April 2022. Patients were examined using clinical, laboratory and instrumental methods once every 2 years. The follow-up period was 1–5 years in 45 (60%) patients and 6–15 years in the remaining 30 (40%) patients. All patients underwent a clinical and standard laboratory work-up with CRP and interleukin 6 levels assessment, as well as ultrasound Dopplerography of peripheral arteries in the color Doppler mapping mode and multislice computed tomography-panaortography.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. Lesions of the common carotid (85.33%) and subclavian (84%) arteries were detected more often. Involvement of the abdominal aorta was noted in 60% of patients and was accompanied by stenosis of the renal arteries in 100% of cases. The clinical picture of the disease was mainly represented by cardiac pathology in the form of arterial hypertension (84%) and aortic regurgitation (68%) with the development of decompensated chronic heart failure in 15% of patients. During the dynamic observation, significant improvement in the course of the disease, clinical symptoms, decrease in the severity of vascular changes were not revealed, with the exception of a decrease in the clinical activity of AT (p&lt;0.05) in one third of patients (37.4%). Conclusion. The severity of clinical manifestations and the course of AT in the Kyrgyz cohort was due to cardiovascular pathology. As dynamic observation showed, the lack of significant improvement in the course of the disease was largely due to the long duration of chronic inflammation, late diagnosis, development of irreversible stenotic, occlusive and aneurysmal changes, as well as the fact that patients did not receive adequate pathogenetic therapy at the onset of the disease. Keywords: &lt;0.05) in one third of patients (37.4%).</p></sec><sec><title>Conclusion</title><p>Conclusion. The severity of clinical manifestations and the course of AT in the Kyrgyz cohort was due to cardiovascular pathology. As dynamic observation showed, the lack of significant improvement in the course of the disease was largely due to the long duration of chronic inflammation, late diagnosis, development of irreversible stenotic, occlusive and aneurysmal changes, as well as the fact that patients did not receive adequate pathogenetic therapy at the onset of the disease.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>артериит Такаясу</kwd><kwd>активность</kwd><kwd>аневризма</kwd><kwd>мониторинг</kwd><kwd>стеноз</kwd><kwd>окклюзия</kwd><kwd>ультразвуковая допплерография</kwd><kwd>томография</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Takayasu's arteritis</kwd><kwd>activity</kwd><kwd>aneurysm</kwd><kwd>monitoring</kwd><kwd>stenosis</kwd><kwd>occlusion</kwd><kwd>ultrasonic dopplerography</kwd><kwd>tomography</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994 Jun 1;120(11):919-29. doi: 10.7326/0003-4819-120-11-199406010-00004.</mixed-citation><mixed-citation xml:lang="en">Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994 Jun 1;120(11):919-29. doi: 10.7326/0003-4819-120-11-199406010-00004.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Watts R, Al-Taiar A, Mooney J, et al. The epidemiology of Takayasu arteritis in the UK. Rheumatology (Oxford). 2009 Aug;48(8): 1008-11. doi: 10.1093/rheumatology/kep153. Epub 2009 Jun 19.</mixed-citation><mixed-citation xml:lang="en">Watts R, Al-Taiar A, Mooney J, et al. The epidemiology of Takayasu arteritis in the UK. Rheumatology (Oxford). 2009 Aug;48(8): 1008-11. doi: 10.1093/rheumatology/kep153. Epub 2009 Jun 19.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Zaldivar Villon ML, de la Rocha JA, Espinoza LR. Takayasu arteritis: recent developments. Curr Rheumatol Rep 2019; 21: 45.</mixed-citation><mixed-citation xml:lang="en">Zaldivar Villon ML, de la Rocha JA, Espinoza LR. Takayasu arteritis: recent developments. Curr Rheumatol Rep 2019; 21: 45.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Toshihiko N. Current status of large and small vessel vasculitis in Japan. Int J Cardiol. 1996 Aug;54 Suppl:S91-8. doi: 10.1016/s0167-5273(96)88777-8.</mixed-citation><mixed-citation xml:lang="en">Toshihiko N. Current status of large and small vessel vasculitis in Japan. Int J Cardiol. 1996 Aug;54 Suppl:S91-8. doi: 10.1016/s0167-5273(96)88777-8.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sharma BK, Jain S, Radotra BD. An autopsy study of Takayasu arteritis in India. Int J Cardiol. 1998 Oct 1;66 Suppl 1:S85-90; discussion S91. doi: 10.1016/s0167-5273(98)00155-7.</mixed-citation><mixed-citation xml:lang="en">Sharma BK, Jain S, Radotra BD. An autopsy study of Takayasu arteritis in India. Int J Cardiol. 1998 Oct 1;66 Suppl 1:S85-90; discussion S91. doi: 10.1016/s0167-5273(98)00155-7.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cong X, Dai S, Feng X, et al. Takayasu’s arteritis: clinical features and outcomes of 125 patients in China. Clin Rheumatol. 2010 Sep; 29(9):973-81. doi: 10.1007/s10067-010-1496-1. Epub 2010 Jun 30.</mixed-citation><mixed-citation xml:lang="en">Cong X, Dai S, Feng X, et al. Takayasu’s arteritis: clinical features and outcomes of 125 patients in China. Clin Rheumatol. 2010 Sep; 29(9):973-81. doi: 10.1007/s10067-010-1496-1. Epub 2010 Jun 30.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dagna L, Salvo F, Tiraboschi M, et al. Pentraxin-3 as a marker of disease activity in takayasu arteritis. Ann Intern Med. 2011 Oct 4;155(7):425-33. doi: 10.7326/0003-4819-155-7-201110040-00005.</mixed-citation><mixed-citation xml:lang="en">Dagna L, Salvo F, Tiraboschi M, et al. Pentraxin-3 as a marker of disease activity in takayasu arteritis. Ann Intern Med. 2011 Oct 4;155(7):425-33. doi: 10.7326/0003-4819-155-7-201110040-00005.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ishihara T, Haraguchi G, Kamiishi T, et al. Sensitive assessment of activity of Takayasu’s arteritis by pentraxin 3, a new biomarker. J Am Coll Cardiol. 2011 Apr 19;57(16):1712-3. doi: 10.1016/j.jacc.2010.10.058.</mixed-citation><mixed-citation xml:lang="en">Ishihara T, Haraguchi G, Kamiishi T, et al. Sensitive assessment of activity of Takayasu’s arteritis by pentraxin 3, a new biomarker. J Am Coll Cardiol. 2011 Apr 19;57(16):1712-3. doi: 10.1016/j.jacc.2010.10.058.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Direskeneli H, Aydin SZ, Merkel PA. Assessment of disease activity and progression in Takayas, s arteritis. Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S86-91. Epub 2011 May 11.</mixed-citation><mixed-citation xml:lang="en">Direskeneli H, Aydin SZ, Merkel PA. Assessment of disease activity and progression in Takayas, s arteritis. Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S86-91. Epub 2011 May 11.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sager S, Yilmaz S, Ozhan M, et al. F-18 Fdg PET/CT findings of a patient with Takayasu arteritis before and after therapy. Mol Imaging Radionucl Ther. 2012 Apr;21(1):32-4. doi: 10.4274/Mirt.021896. Epub 2012 Apr 1.</mixed-citation><mixed-citation xml:lang="en">Sager S, Yilmaz S, Ozhan M, et al. F-18 Fdg PET/CT findings of a patient with Takayasu arteritis before and after therapy. Mol Imaging Radionucl Ther. 2012 Apr;21(1):32-4. doi: 10.4274/Mirt.021896. Epub 2012 Apr 1.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng Y, Lv N, Wang Z, et al. 18-FDGPET in assessing disease activity in Takayasu arteritis: a meta-analysis. Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S22-7. Epub 2013 Feb 25.</mixed-citation><mixed-citation xml:lang="en">Cheng Y, Lv N, Wang Z, et al. 18-FDGPET in assessing disease activity in Takayasu arteritis: a meta-analysis. Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S22-7. Epub 2013 Feb 25.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Papa M, De Cobelli F, Baldissera E, et al. Takayasu arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity. AJR Am J Roentgenol. 2012 Mar;198(3):W279-84. doi: 10.2214/AJR.11.7360.</mixed-citation><mixed-citation xml:lang="en">Papa M, De Cobelli F, Baldissera E, et al. Takayasu arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity. AJR Am J Roentgenol. 2012 Mar;198(3):W279-84. doi: 10.2214/AJR.11.7360.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt WA. Imaging in vasculitis. Best Pract Res Clin Rheumatol. 2013 Feb;27(1): 107-18. doi: 10.1016/j.berh.2013.01.001.</mixed-citation><mixed-citation xml:lang="en">Schmidt WA. Imaging in vasculitis. Best Pract Res Clin Rheumatol. 2013 Feb;27(1): 107-18. doi: 10.1016/j.berh.2013.01.001.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu FP, Luo S, Wang ZJ, et al. Takayasu arteritis: imaging spectrum at multidetector CT angiography. Br J Radiol. 2012 Dec;85 (1020):e1282-92. doi: 10.1259/bjr/25536451.</mixed-citation><mixed-citation xml:lang="en">Zhu FP, Luo S, Wang ZJ, et al. Takayasu arteritis: imaging spectrum at multidetector CT angiography. Br J Radiol. 2012 Dec;85 (1020):e1282-92. doi: 10.1259/bjr/25536451.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990 Aug;33(8):1129-34. doi: 10.1002/art.1780330811.</mixed-citation><mixed-citation xml:lang="en">Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990 Aug;33(8):1129-34. doi: 10.1002/art.1780330811.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Sharma BK, Jain S, Suri S, et al. Diagnostic criteria for Takayasu arteritis. Int J Cardiol. 1996 Aug;54 Suppl:S141-7. doi: 10.1016/s0167-5273(96)88783-3.</mixed-citation><mixed-citation xml:lang="en">Sharma BK, Jain S, Suri S, et al. Diagnostic criteria for Takayasu arteritis. Int J Cardiol. 1996 Aug;54 Suppl:S141-7. doi: 10.1016/s0167-5273(96)88783-3.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Misra R, Danda D, Rajappa SM, et al. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology (Oxford). 2013 Oct;52(10):1795-801. doi: 10.1093/rheumatology/ket128. Epub 2013 Apr 16.</mixed-citation><mixed-citation xml:lang="en">Misra R, Danda D, Rajappa SM, et al. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology (Oxford). 2013 Oct;52(10):1795-801. doi: 10.1093/rheumatology/ket128. Epub 2013 Apr 16.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Zoghbi WA , Adams D , Bonow RO . Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the american society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J Am Soc Echocardiogr. 2017Apr;30(4):303-71. doi:10.1016/j.echo.2017.01.007. Epub 2017 Mar 14.</mixed-citation><mixed-citation xml:lang="en">Zoghbi WA , Adams D , Bonow RO . Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the american society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J Am Soc Echocardiogr. 2017Apr;30(4):303-71. doi:10.1016/j.echo.2017.01.007. Epub 2017 Mar 14.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Barnett HJM, Taylor DW, Haynes RB, et al; North American Symptomatic Carotid Endar-erectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med. 1991 Aug 15;325(7):445-53. doi: 10.1056/NEJM199108153250701.</mixed-citation><mixed-citation xml:lang="en">Barnett HJM, Taylor DW, Haynes RB, et al; North American Symptomatic Carotid Endar-erectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med. 1991 Aug 15;325(7):445-53. doi: 10.1056/NEJM199108153250701.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998 May 9;351(9113): 1379-87.</mixed-citation><mixed-citation xml:lang="en">Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998 May 9;351(9113): 1379-87.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hata A, Noda M, Moriwaki R, et al. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol. 1996 Aug;54 Suppl:S155-63. doi: 10.1016/s0167-5273(96)02813-6.</mixed-citation><mixed-citation xml:lang="en">Hata A, Noda M, Moriwaki R, et al. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol. 1996 Aug;54 Suppl:S155-63. doi: 10.1016/s0167-5273(96)02813-6.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Jefferson R, Roberts MD. Takayasu Arteritis Differential Diagnoses. Medscape-2016. http://emedicine.medscape.com/article/332378-differential.</mixed-citation><mixed-citation xml:lang="en">Jefferson R, Roberts MD. Takayasu Arteritis Differential Diagnoses. Medscape-2016. http://emedicine.medscape.com/article/332378-differential.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa K. Natural history and classification of occlusive thromboaortopathy (Takayasu’s disease). Circulation. 1978 Jan;57(1): 27-35. doi: 10.1161/01.cir.57.1.27.</mixed-citation><mixed-citation xml:lang="en">Ishikawa K. Natural history and classification of occlusive thromboaortopathy (Takayasu’s disease). Circulation. 1978 Jan;57(1): 27-35. doi: 10.1161/01.cir.57.1.27.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol. 1998 Oct 1;66 Suppl 1:S191-4; discussion S195. doi: 10.1016/s0167-5273(98)00181-8.</mixed-citation><mixed-citation xml:lang="en">Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol. 1998 Oct 1;66 Suppl 1:S191-4; discussion S195. doi: 10.1016/s0167-5273(98)00181-8.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Dagna L, Salvo F, Tiraboschi M, et al. Pentraxin-3 as a marker of disease activity in takayasu arteritis. Ann Intern Med. 2011 Oct 4; 155(7):425-33. doi: 10.7326/0003-4819-155-7-201110040-00005.</mixed-citation><mixed-citation xml:lang="en">Dagna L, Salvo F, Tiraboschi M, et al. Pentraxin-3 as a marker of disease activity in takayasu arteritis. Ann Intern Med. 2011 Oct 4; 155(7):425-33. doi: 10.7326/0003-4819-155-7-201110040-00005.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Moriwaki R, Numano F. Takayasu arteritis: follow-up studies for 20 years. Heart Vessels Suppl. 1992;7:138-45. doi: 10.1007/BF01744560.</mixed-citation><mixed-citation xml:lang="en">Moriwaki R, Numano F. Takayasu arteritis: follow-up studies for 20 years. Heart Vessels Suppl. 1992;7:138-45. doi: 10.1007/BF01744560.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Cieslik P, Hrycek A. Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications. Autoimmunity. 2012 Mar;45(2):119-28. doi: 10.3109/08916934.2011.611549. Epub 2011 Oct 11.</mixed-citation><mixed-citation xml:lang="en">Cieslik P, Hrycek A. Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications. Autoimmunity. 2012 Mar;45(2):119-28. doi: 10.3109/08916934.2011.611549. Epub 2011 Oct 11.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Eichhorn J, Sima D, Thiele B, et al. Antiendothelial cell antibodies in Takayasu arteritis. Circulation. 1996 Nov 15;94(10):2396-401. doi: 10.1161/01.cir.94.10.2396.</mixed-citation><mixed-citation xml:lang="en">Eichhorn J, Sima D, Thiele B, et al. Antiendothelial cell antibodies in Takayasu arteritis. Circulation. 1996 Nov 15;94(10):2396-401. doi: 10.1161/01.cir.94.10.2396.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Wang H, Ma J, Wu Q, et al. Circulating B lymphocytes producing autoantibodies to endothelial cells play a role in the pathogenesis of Takayasu arteritis. J Vasc Surg. 2011 Jan; 53(1):174-80. doi: 10.1016/j.jvs.2010.06.173. Epub 2010 Sep 15.</mixed-citation><mixed-citation xml:lang="en">Wang H, Ma J, Wu Q, et al. Circulating B lymphocytes producing autoantibodies to endothelial cells play a role in the pathogenesis of Takayasu arteritis. J Vasc Surg. 2011 Jan; 53(1):174-80. doi: 10.1016/j.jvs.2010.06.173. Epub 2010 Sep 15.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. 2007 Mar;56(3):1000-9. doi: 10.1002/art.22404.</mixed-citation><mixed-citation xml:lang="en">Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. 2007 Mar;56(3):1000-9. doi: 10.1002/art.22404.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Schneeweis C, Schnackenburg B, Stuber M, et al. Delayed contrast-enhanced MRI of the coronary artery wall in takayasu arteritis. PLoS One. 2012;7(12):e50655. doi: 10.1371/journal.pone.0050655. Epub 2012 Dec 7.</mixed-citation><mixed-citation xml:lang="en">Schneeweis C, Schnackenburg B, Stuber M, et al. Delayed contrast-enhanced MRI of the coronary artery wall in takayasu arteritis. PLoS One. 2012;7(12):e50655. doi: 10.1371/journal.pone.0050655. Epub 2012 Dec 7.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Yamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: diagnosis with breath-hold contrast-enhanced three-dimensional MR angiography. J Magn Reson Imaging. 2000 May;11(5):481-7. doi: 10.1002/(sici)1522-2586(200005)11:53.0.co;2-4.</mixed-citation><mixed-citation xml:lang="en">Yamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: diagnosis with breath-hold contrast-enhanced three-dimensional MR angiography. J Magn Reson Imaging. 2000 May;11(5):481-7. doi: 10.1002/(sici)1522-2586(200005)11:53.0.co;2-4.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Eshet Y, Pauzner R, Goitein O, et al. The limited role of MRI in long-term followup of patients with Takayasu’s arteritis. Autoimmun Rev. 2011 Dec;11(2):132-6. doi: 10.1016/j.autrev.2011.09.002. Epub 2011 Sep 17.</mixed-citation><mixed-citation xml:lang="en">Eshet Y, Pauzner R, Goitein O, et al. The limited role of MRI in long-term followup of patients with Takayasu’s arteritis. Autoimmun Rev. 2011 Dec;11(2):132-6. doi: 10.1016/j.autrev.2011.09.002. Epub 2011 Sep 17.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Yadav MK. Takayasu arteritis: clinical and CT-angiography profile of 25 patients and a brief review of literature. Indian Heart J. 2007 Nov-Dec;59(6):468-74.</mixed-citation><mixed-citation xml:lang="en">Yadav MK. Takayasu arteritis: clinical and CT-angiography profile of 25 patients and a brief review of literature. Indian Heart J. 2007 Nov-Dec;59(6):468-74.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2009 Mar;68(3):318-23. doi: 10.1136/ard.2008.088351. Epub 2008 Apr 15.</mixed-citation><mixed-citation xml:lang="en">Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2009 Mar;68(3):318-23. doi: 10.1136/ard.2008.088351. Epub 2008 Apr 15.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
